Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Carter

Showing results (381-390 of 1,522) with videos related to

Pageof 153
Sort By:
Archives of Virology|February 18, 2005
Inhibition of VSV and EMCV replication by the interferon-induced GTPase, mGBP-2: differential requirement for wild-type GTP binding domainC C Carter, V Y Gorbacheva, D J Vestal
Life Sciences|March 1, 1978
Neuroendocrine function in Huntington's disease: dopaminergic regulation of prolactin releaseE Caine, R Kartzinel, M Ebert, et al.
Journal of Clinical Pharmacology|May 1, 1978
Effects of halofenate on glucose tolerance in patients with hyperlipoproteinemiaE B Feldman, F B Gluck, A C Carter
Current Opinion in Psychology|March 4, 2022
Social media and self-esteemDrew P Cingel, Michael C Carter, Hannes-Vincent Krause
The British Journal of Surgery|November 1, 1981
Biliary surgery in the same admission for gallstone-associated acute pancreatitisD H Osborne, C W Imrie, D C Carter
British Journal of Obstetrics and Gynaecology|March 1, 1984
Normal levels of active contraction area in spontaneous labourP J Steer, M C Carter, R W Beard
The Journal of Biological Chemistry|February 15, 1993
Growth hormone-promoted tyrosyl phosphorylation of a 121-kDa growth hormone receptor-associated proteinX Wang, C Möller, G Norstedt, et al.
Journal of the American Academy of Dermatology|February 1, 1993
Peripheral neuropathy during etretinate therapy for psoriasisC J Hammer, C C Carter, J M Hanifin
Molecular and Cellular Biochemistry|September 20, 1996
Suppression of beta-oxidation restores pyruvate inhibition of pyruvate dehydrogenase kinase in starved rat heartT C Carter, D D Ramdath, H G Coore
Clinical and Diagnostic Laboratory Immunology|January 5, 1999
The cured immune phenotype achieved by treatment of visceral leishmaniasis in the BALB/c mouse with a nonionic surfactant vesicular formulation of sodium stibogluconate does not protect against reinfectionK C Carter, A J Baillie, A B Mullen
Pageof 153

Showing results (381-390 of 1,522) with videos related to

Sort By:
Pageof 153
Archives of Virology|February 18, 2005
Inhibition of VSV and EMCV replication by the interferon-induced GTPase, mGBP-2: differential requirement for wild-type GTP binding domainC C Carter, V Y Gorbacheva, D J Vestal
Life Sciences|March 1, 1978
Neuroendocrine function in Huntington's disease: dopaminergic regulation of prolactin releaseE Caine, R Kartzinel, M Ebert, et al.
Journal of Clinical Pharmacology|May 1, 1978
Effects of halofenate on glucose tolerance in patients with hyperlipoproteinemiaE B Feldman, F B Gluck, A C Carter
Current Opinion in Psychology|March 4, 2022
Social media and self-esteemDrew P Cingel, Michael C Carter, Hannes-Vincent Krause
The British Journal of Surgery|November 1, 1981
Biliary surgery in the same admission for gallstone-associated acute pancreatitisD H Osborne, C W Imrie, D C Carter
British Journal of Obstetrics and Gynaecology|March 1, 1984
Normal levels of active contraction area in spontaneous labourP J Steer, M C Carter, R W Beard
The Journal of Biological Chemistry|February 15, 1993
Growth hormone-promoted tyrosyl phosphorylation of a 121-kDa growth hormone receptor-associated proteinX Wang, C Möller, G Norstedt, et al.
Journal of the American Academy of Dermatology|February 1, 1993
Peripheral neuropathy during etretinate therapy for psoriasisC J Hammer, C C Carter, J M Hanifin
Molecular and Cellular Biochemistry|September 20, 1996
Suppression of beta-oxidation restores pyruvate inhibition of pyruvate dehydrogenase kinase in starved rat heartT C Carter, D D Ramdath, H G Coore
Clinical and Diagnostic Laboratory Immunology|January 5, 1999
The cured immune phenotype achieved by treatment of visceral leishmaniasis in the BALB/c mouse with a nonionic surfactant vesicular formulation of sodium stibogluconate does not protect against reinfectionK C Carter, A J Baillie, A B Mullen
Pageof 153